HEMA News 0.2100 Hemacare Corp (HEMA)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hemacare Corp (HEMA) 0.2100 $HEMA

2013 Report on the International Apheresis Equipment Market - Trends and Forecasts to 2018
M2 - Wed Jan 22, 8:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/ft7f6d/apheresis) has announced the addition of the "2013 Report on the International Apheresis Equipment Market - Trends and Forecasts to 2018" report to their offering. This report covers the performance of various segments of the apheresis market in terms of revenues generated in such segments. The overall market is classified on the basis of the types of applications of apheresis, different procedural modalities of therapeutic apheresis, various technologies employed, and the types of equipment used in apheresis. The report provides in-depth analysis of the sub-segments of the market with their estimated forecast of market size from 2010 to 2018. The data analyses the estimated revenues and forecast of these major applications for the period 2012 - 2018. Similar analysis is performed for the procedure modalities of apheresis and types of technology used in therapeutic apheresis. This report also includes analysis of the global apheresis equipment market, which is further segmented on the basis of geographical distribution. The overall analysis of the competitiveness of the global apheresis equipment market is covered in the report. The above mentioned key analysis with recommendations would be of assistance in taking strategic decisions related to the market. This research is specifically prepared to analyze and estimate the performance of the major apheresis equipment segments in the global market. The study also presents a comprehensive assessment of the major strategies of the market stakeholders and their winning imperatives by segmenting the market as follows: Key Topics Covered: 1 Introduction 2 Executive Summary 3 Apheresis Equipment Market Overview 4 Global Apheresis Equipment Market, By Applications 5 Apheresis Equipment Market, By Types Of Procedures 6 Global Apheresis Machines Market, By Technology 7 Global Apheresis Equipment Market, By Geography 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Asahi Kasei Kuraray Medical Co., Ltd. - B. Braun Melsungen AG - Fenwal, Inc. - Haemonetics Corp. - Hemacare Corporation - Terumo BCT, Inc. - Therakos, Inc. For more information visit http://www.researchandmarkets.com/research/ft7f6d/apheresis

Global Apheresis Equipment Market Report 2013 - 2018
M2 - Mon Nov 18, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/jlpwt8/apheresis) has announced the addition of the "Global Apheresis Equipment Market Report 2013 - 2018" report to their offering. The applications equipment market is classified on the basis of types of clinical areas in which the apheresis procedure is employed. The report covers the analysis of the estimated revenues and forecast of these major applications for the period 2012 - 2018. Similar analysis is performed for the procedure modalities of apheresis and types of technology used in therapeutic apheresis. This report also includes analysis of the global apheresis equipment market, which is further segmented on the basis of geographical distribution. The overall analysis of the competitiveness of the global apheresis equipment market is covered in the report. The above mentioned key analysis with recommendations would be of assistance in taking strategic decisions related to the market. Further, this report also covers the major firms that are active in the apheresis market. The company profiles included in the report will be of significant help in understanding the tactical overview of the market. The company profiling performed in the report covers the financial and strategic properties, SWOT analysis, and the recent developments of the major players of the global apheresis market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Apheresis Equipment Market Overview 3.1 Introduction 3.2 Therapeutic Apheresis 3.3 Donor Apheresis 3.4 Market Dynamics 3.5 Porter's Five Forces Analysis 3.6 Market Attractiveness Analysis 3.7 Market Share Analysis, 2011 4 Global Apheresis Equipment Market, By Applications 4.1 Introduction 4.2 Neurological Disorders 4.3 Hematology 4.4 Renal Disorders 4.5 Others 5 Apheresis Equipment Market, By Types Of Procedures 5.1 Introduction 5.2 Plasmapheresis 5.3 Photopheresis 5.4 Leukapheresis 5.5 Plateletpheresis 5.6 LDL Apheresis 5.7 Erythrocytapheresis 5.8 Others (Lymphapheresis, Lipidpheresis) 6 Global Apheresis Machines Market, By Technology 7 Global Apheresis Equipment Market, By Geography 7.1 Introduction 7.2 North America 7.3 Europe 7.4 Asia Pacific 7.5 Rest Of World 8 Competitive Landscape 8.1 Introduction 8.2 Major Strategies By Key Players 8.3 Recommendations 9 Company Profiles Companies Mentioned - Asahi Kasei Kuraray Medical Co., Ltd. - B. Braun Melsungen AG - Fenwal, Inc. - Haemonetics Corp. - Hemacare Corporation - Terumo BCT, Inc. - Therakos, Inc. For more information visit http://www.researchandmarkets.com/research/jlpwt8/apheresis

2013 Report on the Worldwide Apheresis Market - with Forecasts to 2017
M2 - Fri Nov 01, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7b5s5q/apheresis_market) has announced the addition of the "2013 Report on the Worldwide Apheresis Market - with Forecasts to 2017" report to their offering. Apheresis involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. Apheresis applications market studied in this report is segmented as plasmapheresis, plateletapheresis, erythrocytapheresis, leukapheresis, and other applications based on the various components collected in apheresis collection and therapeutic apheresis. The apheresis market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market. The global apheresis market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017 growing at a CAGR of 11.0% from 2012 to 2017. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Apheresis Market, By Procedure 5 Global Apheresis Market, By Product Type 6 Global Apheresis Market, By Technology 7 Global Apheresis Market, By Application 8 Geographic Analysis 8.1 Introduction 8.2 North America 8.3 Europe 8.4 Asia 8.5 Row (Rest Of The World) 9 Competitive Landscape 9.1 Introduction 9.2 Mergers & Acquisitions 9.3 Agreements, Partnerships, Collaborations & Joint Ventures 9.4 Products Launch 9.5 Expansions 9.6 Other Developments 9.7 Approvals 10 Company Profiles Companies Mentioned - Asahi Kasei Medical - B. Braun Melsungen - Cerus Corporation - Fenwal - Fresenius Medical Care Ag & Co - Haemonetics Corporation - Hemacare Corporation - Kaneka Corporation - Kawasumi Laboratories - Medica S.P.A - Nikkiso Co - Terumo Bct - Therakos For more information visit http://www.researchandmarkets.com/research/7b...sis_market

BioLife Solutions Announces Strategic Partnership with HemaCare
PR Newswire - Tue Jun 25, 5:00AM CDT
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, (OTCPK:HEMA), a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic relationship wherein HemaCare will market BioLife's HypoThermosol® and CryoStor® biopreservation media products and HemaCare's blood derived cells to the research and clinical communities.

HemaCare Reports Improved Six Month and Year End Results
Business Wire - Mon Mar 18, 8:00AM CDT
HemaCare Corporation (HEMA) today reported its financial results for the six months and year ended December 31, 2012. For the six month period, revenue rose by 13% to $9.2 million, while the loss from continuing operations decreased by 83% to $214,000 when compared to the year-earlier period. For the year ended December 31, 2012, revenue rose by 10% to $17.9 million, while the loss from continuing operations decreased by 65% to $758,000 compared to the year-earlier period. Total Company income was $1,163,000 for the year ended December 31, 2012 compared with a total Company loss of $805,000 for the year ended December 31, 2011.

Apheresis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
M2 - Thu Feb 28, 10:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/ztn2dt/apheresis) has announced the addition of the "Apheresis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering. Apheresis Equipment Market (Plasmapheresis, Photopheresis, Apheresis in Neurological, Renal, Hematological Diseases, Centrifugation, Membrane Filtration, Apheresis Machines and Disposable Kits) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 This report on the global apheresis equipment market includes the different facets of therapeutic apheresis, donor apheresis, and the apheresis devices market. The report covers the performance of various segments of the apheresis market in terms of revenues generated in such segments. The overall market is classified on the basis of the types of applications of apheresis, different procedural modalities of therapeutic apheresis, various technologies employed, and the types of equipmen

Apheresis Market - Applications, Procedures, Devices & Disposables - Forecasts To 2017
M2 - Wed Jan 16, 9:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/sfgngk/apheresis_market) has announced the addition of the "Apheresis Market - Applications (Plasmapheresis, Plateletpheresis,RBC/Erythrocytapheresis,Leukapheresis,Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables - Forecasts To 2017" report to their offering. Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component. Apheresis involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. Apheresis applications market studied in this report is segmented as plasmapheresis, plateletapheresis, erythrocytapheresis, leukapheresis, and other applications based on the various components collected in apheresis collection
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 21

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
SDG&E's 21-Year Reliability Run Has Real Investor Weight

Updated Category News Views 66

Seventy minutes without power in a year is the sort of number most people ignore until their refrigerator quits humming. For San Diego Gas & Electric customers, though, it is a meaningful operating result: roughly 70 minutes annually from unplanned outages, on average, over the past decade, alongside fewer than one sustained outage per customer each year. SDG&E has also...

Continue Reading
Corner Bakery Bets on Holiday Catering Convenience

Updated Category News Views 150

A $50 carrot on a $350 catering tab tells you exactly where Corner Bakery sees the holiday battlefield: not in one lonely cookie sale, but in the larger group order that can make a restaurant’s day. The chain is pushing holiday catering through November and December, pairing that discount with bakery trays, meals for groups and a promise to handle delivery setup. It is...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 7

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
SOCi's MCP Push Makes Context the Product Moat Bigger

Updated Category News Views 135

Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 95

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 38

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
Siteimprove Turns Accessibility Checks Into Agent Spend

Updated Category News Views 180

Accessibility work has usually been the thing teams promise to fix after the launch party is over. Siteimprove is trying to shove that discipline directly into the AI-agent workflow, announcing on November 19, 2026 that its Siteimprove.ai Accessibility Agent is available through Agentic Commerce on AWS Marketplace. The practical hook is simple enough: an AI agent can...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 65

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 110

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading

Top 5 Most Recently Viewed Articles

Pharvaris Shares Promising Data on Deucrictibant Efficacy

Updated Category News Views 186

Pharvaris Highlights Clinical Progress in HAE Treatment At the recent AAAAI/WAO Joint Congress, Pharvaris presented compelling long-term clinical data supporting the use of deucrictibant, a novel oral treatment for hereditary angioedema (HAE). This data underscores the drug's potential to not only prevent but also effectively address HAE attacks, offering hope to those...

Continue Reading
First Horizon Opens New Banking Center Celebrating Local Pride

Updated Category News Views 349

First Horizon Unveils New Banking Center with Appalachian Spirit First Horizon Bank (NYSE: FHN) proudly celebrated the grand opening of its newly refreshed banking center. The location pays tribute to the vibrant Appalachian State community, showcasing a striking theme that reflects its strong ties with Appalachian State University and its athletics. This celebration...

Continue Reading
Understanding Namodenoson's Role in Liver Cancer and Beyond

Updated Category News Views 243

Innovative Research on Namodenoson’s Impact in Liver Cancer Therapy Namodenoson, developed by Can-Fite BioPharma Ltd., is making waves in the medical community as a promising candidate for liver cancer treatment. Unlike traditional chemotherapy, which often harms healthy cells, Namodenoson is lauded for its protective qualities towards normal body systems. Published...

Continue Reading
Geotab Enhances Public Sector Solutions with Technological Advancements

Updated Category News Views 147

Geotab Enhances Public Sector Solutions with Technological Advancements Geotab Inc., a leader in connected vehicle solutions and asset management, has taken a major step forward in serving the public sector by expanding its cooperative purchasing contracts with Sourcewell and Canoe Procurement Group. This expansion introduces four cutting-edge solutions aimed at enhancing...

Continue Reading
Dun & Bradstreet Earns TRUSTe Certification for Responsible AI

Updated Category News Views 351

Dun & Bradstreet Achieves TRUSTe Responsible AI Certification Dun & Bradstreet (NYSE:DNB), recognized globally as a leading provider of business decisioning data and analytics, has been awarded the TRUSTe Responsible AI Certification. This certification signifies the company’s commitment to ethical and responsible governance in the realm of artificial intelligence (AI)....

Continue Reading